Anuh Pharma Limited — Agreements (Sub-para 5-Para B)

Anuh Pharma Limited has informed the stock exchanges regarding certain agreements falling under sub-paragraph 5 of Para B. The company has disclosed these details to ensure transparency and compliance with regulatory norms. While the specific nature of these agreements has not been detailed in the public announcement, such disclosures are standard practice for corporate governance.

For investors, this update serves as a procedural notification rather than a signal of significant market-moving news. It confirms that the company is actively managing its business relationships and documentation. As the company has not provided further specifics, the immediate impact on the stock price is expected to be neutral.

Investors should monitor the company's subsequent filings for more clarity on the scope and value of these agreements. Keeping an eye on future quarterly results will also be essential to gauge how these business arrangements contribute to the company's overall performance and growth trajectory.